Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk of low bone mineral density in patients with rheumatoid arthritis treated with biologics ; volume:16 ; number:1 ; day:30 ; month:9 ; year:2015 ; pages:1-6 ; date:12.2015
BMC musculoskeletal disorders ; 16, Heft 1 (30.9.2015), 1-6, 12.2015
- Urheber
-
Takahashi, Kengo
- Beteiligte Personen und Organisationen
-
Setoguchi, Takao
Tawaratsumida, Hiroki
Arishima, Yoshiya
Tominaga, Hiroyuki
Ishidou, Yasuhiro
Nagano, Satoshi
Shigemizu, Sanae
Aoki, Noriko
Akimoto, Masaki
Otsubo, Hideo
Matsuda, Takemasa
Kakoi, Hironori
Izumi, Toshihiko
Nakamura, Shunsuke
Yokouchi, Masahiro
Sunahara, Nobuhiko
Komiya, Setsuro
SpringerLink (Online service)
- DOI
-
10.1186/s12891-015-0732-x
- URN
-
urn:nbn:de:1111-2016110518391
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takahashi, Kengo
- Setoguchi, Takao
- Tawaratsumida, Hiroki
- Arishima, Yoshiya
- Tominaga, Hiroyuki
- Ishidou, Yasuhiro
- Nagano, Satoshi
- Shigemizu, Sanae
- Aoki, Noriko
- Akimoto, Masaki
- Otsubo, Hideo
- Matsuda, Takemasa
- Kakoi, Hironori
- Izumi, Toshihiko
- Nakamura, Shunsuke
- Yokouchi, Masahiro
- Sunahara, Nobuhiko
- Komiya, Setsuro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Real-world retention rates of biologics in patients with rheumatoid arthritis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Seronegative and seropositive rheumatoid arthritis treated with rituximab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine
Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Real-world retention rates of biologics in patients with rheumatoid arthritis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Seronegative and seropositive rheumatoid arthritis treated with rituximab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine
Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice
Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis
Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis
Real-world retention rates of biologics in patients with rheumatoid arthritis
Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics
Drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with rheumatoid arthritis: the ANSWER cohort study
Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care
Seronegative and seropositive rheumatoid arthritis treated with rituximab
Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine
Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice